肝癌靶向治疗靶点的研究进展  

Advances in targeted spot of hepatocellular carcinoma targeted therapy

作　　者：田宇航[1] 刘钊[1] 梁锡天 程文[1] 

机构地区：[1]哈尔滨医科大学附属肿瘤医院超声科,黑龙江哈尔滨150081

出　　处：《现代肿瘤医学》2018年第5期776-779,共4页Journal of Modern Oncology

基　　金：国家自然科学基金资助项目(编号:81571682)

摘　　要：随着现代医学的不断发展,医疗整体水平的进一步提高,肝癌的治疗手段已经不仅仅局限于几种传统手段,如手术切除、放射治疗和化学治疗,众多医学同仁正致力于研发更加有效的治疗手段。自20世纪80年代起,靶向治疗走进了人们的视线,经过不断的探索和研究,正逐渐成为肝癌治疗的主要途径之一。据报道肝癌的靶向治疗方法多种多样,但都不同程度地提高了肝癌的治疗效果,本文主要从受体靶点、肽靶点、标志性分子靶点这三个方面进行概述。With the continuous development of modern medicine, and further improving the overall level of medicine care, the treatment of liver cancer has not only been limited to several traditional means such as surgery, radiotherapy and chemotherapy. Many medical colleagues are working to develop more effective treatment. Since 1980s,targeted therapy comes into the people s attention. Through the continuous exploration and research, it is gradually becoming one of the main ways of treatment in liver cancer. It is reported that the targeted therapy for liver cancer is varied, but the treatment effect of liver cancer is improved in different degree. Through reading a lot of literature in recent years, this article marked the summary mainly about the receptor target, peptide target and molecular target.

关 键 词：肝癌 靶点 靶向治疗 

分 类 号：R735.7[医药卫生—肿瘤]